Taysha
development of a gene therapy for syndrome requires regulated expression of | Taysha
Company
Deck Type
IPO
Sector
Industry
Deck date
September 2020
Slide
30 of 66
Related slides by other companies
Genprex
Investor Presentation
October 2022
advancing gene therapy in large indications | Genprex
Genprex
Investor Presentation
October 2022
tumor suppressor genes deleted during cancer development | Genprex
GreenLight
SPAC
August 2021
developing proof of concept for novel based approach to gene therapy | GreenLight
Enochian Biosciences
Results
August 2023
pipelines two complementary therapeutic approaches from cell platform cell vaccine cell therapy one sub licensed gene therapy technology | Enochian Biosciences
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io